{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:11:51Z","timestamp":1780585911335,"version":"3.54.1"},"reference-count":25,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"2","funder":[{"name":"HIMEDIC, Inc."},{"name":"Siemens Japan KK"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2463\/mrms.mp.2023-0147","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T22:11:19Z","timestamp":1707257479000},"page":"176-183","source":"Crossref","is-referenced-by-count":1,"title":["Axillary Lymphadenopathy after COVID-19 Vaccination: Follow-up for Enlarged Lymph Nodes on MR Imaging"],"prefix":"10.2463","volume":"24","author":[{"given":"Noriko","family":"Kanemaru","sequence":"first","affiliation":[{"name":"Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan"},{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Computational Diagnostic Radiology and Preventive Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tu W, Gierada DS, Joe BN. Covid-19 vaccination-related lymphadenopathy: What to be aware of. Radiol Imaging Cancer 2021; 3:e210038.","DOI":"10.1148\/rycan.2021210038"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Becker AS, Perez-Johnston R, Chikarmane SA, et al. Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology scientific expert panel. Radiology 2021; 300:E323\u2013E327.","DOI":"10.1148\/radiol.2021210436"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. van Nijnatten TJA, Jochelson MS, Lobbes MBI. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality. Eur J Radiol 2022; 152:110334.","DOI":"10.1016\/j.ejrad.2022.110334"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zhang M, Ahn RW, Hayes JC, Seiler SJ, Mootz AR, Porembka JH. Axillary lymphadenopathy in the COVID-19 era: What the radiologist needs to know. Radiographics 2022; 42:1897\u20131911.","DOI":"10.1148\/rg.220045"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wolfson S, Kim E, Plaunova A, et al. Erratum: Axillary adenopathy after COVID-19 vaccine: No reason to delay screening mammogram. Radiology 2022; 303:297\u2013299.","DOI":"10.1148\/radiol.213227"},{"key":"6","unstructured":"6. Grimm L, Srini A, Dontchos B, et al. Revised SBI recommendations for the management of axillary adenopathy in patients with recent COVID-19 vaccination. Society of Breast Imaging Patient Care and Delivery Committee. 2022:2020\u20132023."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wolfson S, Kim E. Breast cancer screening and axillary adenopathy in the era of COVID-19 vaccination. Radiology 2023; 306:e222040.","DOI":"10.1148\/radiol.222040"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Igual-Rouilleault AC, Soriano I, Quan PL, Fern\u00e1ndez-Montero A, Elizalde A, Pina L. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation. Eur Radiol 2022; 32:3199\u20133206.","DOI":"10.1007\/s00330-021-08309-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ha SM, Chu AJ, Lee JB, et al. US evaluation of axillary lymphadenopathy following COVID-19 vaccination: A prospective longitudinal study. Radiology 2022; 305:46\u201353.","DOI":"10.1148\/radiol.220543"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Park JY, Lee JY, Yi SY. Axillary lymphadenopathy on ultrasound after COVID-19 vaccination and its influencing factors: A single-center study. J Clin Med 2022; 11:238.","DOI":"10.3390\/jcm11010238"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lane EG, Eisen CS, Drotman MB, et al. Time for resolution of COVID-19 vaccine-related axillary lymphadenopathy and associated factors. AJR Am J Roentgenol 2022; 219:559\u2013568.","DOI":"10.2214\/AJR.22.27687"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mema E, Lane EG, Drotman MB, et al. Axillary lymphadenopathy after a COVID-19 vaccine booster dose: Time to resolution on ultrasound follow-up and associated factors. AJR Am J Roentgenol 2023; 221:175-183.","DOI":"10.2214\/AJR.22.28970"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fiaschetti V, Ubaldi N, De Fazio S, Cossu E. Easy scheme outlining the various morphological and vascular abnormalities of the lymph node structure associated with recent COVID-19 vaccination, each with a different clinical\/diagnostic management. J Pers Med 2022; 12:1371.","DOI":"10.3390\/jpm12091371"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Marcon M, Catanese C, Scarano AL, et al. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: A single-centre experience in 285 women. Radiol Med 2023; 128:1217\u20131224.","DOI":"10.1007\/s11547-023-01696-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Plaza MJ, Wright J, Fernandez S. COVID-19 vaccine-related unilateral axillary lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment. Clin Imaging 2021; 80:139\u2013141.","DOI":"10.1016\/j.clinimag.2021.07.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mukai K, Tsunoda H, Imai R, et al. The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination. Jpn J Radiol 2023; 41:617\u2013624.","DOI":"10.1007\/s11604-023-01387-1"},{"key":"17","unstructured":"17. Parikh R, Feigin KN, Sevilimedu V, Huayanay J, Pinker K, Horvat J V. Comparison of axillary lymph nodes on breast MRI before and after COVID-19 booster vaccination. Acad Radiol 2023 2023; 16: S1076-6332(23)00124-1."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yoshikawa T, Miki S, Nakao T, Koshino S, Hayashi N, Abe O. Axillary lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 vaccination: MRI evaluation. Radiology 2023; 306:270\u2013278.","DOI":"10.1148\/radiol.220814"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liang F, Lindgren G, Lin A, et al. Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Mol Ther 2017; 25:2635\u20132647.","DOI":"10.1016\/j.ymthe.2017.08.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383:2603\u20132615.","DOI":"10.1056\/NEJMoa2034577"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Donners R, Yiin RSZ, Blackledge M, Koh D-M. Whole-body diffusion-weighted MRI of normal lymph nodes: Prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort. Cancer Imaging 2021; 21:64.","DOI":"10.1186\/s40644-021-00432-4"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim EJ, Kim SH, Kang BJ, Choi BG, Song BJ, Choi JJ. Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: Diffusion-weighted MRI and conventional MRI. Magn Reson Imaging 2014; 32:1230\u20131236.","DOI":"10.1016\/j.mri.2014.07.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sui WF, Chen X, Peng ZK, Ye J, Wu JT. The diagnosis of metastatic axillary lymph nodes of breast cancer by diffusion weighted imaging: A meta-analysis and systematic review. World J Surg Oncol 2016; 14:155.","DOI":"10.1186\/s12957-016-0906-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fardanesh R, Thakur SB, Sevilimedu V, et al. Differentiation between benign and metastatic breast lymph nodes using apparent diffusion coefficients. Front Oncol 2022; 12:795265.","DOI":"10.3389\/fonc.2022.795265"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mema E, Lane EG, Drotman MB, et al. Axillary lymphadenopathy after a COVID-19 vaccine booster dose: Time to resolution on ultrasound follow-up and associated factors. AJR Am J Roentgenol 2023; 221:175\u2013183.","DOI":"10.2214\/AJR.22.28970"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/24\/2\/24_mp.2023-0147\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:17:33Z","timestamp":1743826653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/24\/2\/24_mp.2023-0147\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.mp.2023-0147","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"mp.2023-0147"}}